Dec 17 (Reuters) - Drugmaker Pfizer on Tuesday

said it was expecting its 2025 profits to be roughly in line

with Wall Street expectations as it seeks to fend off criticism

over its turnaround strategy from activist hedge fund Starboard

Value.

The company expects adjusted profit per share of $2.80 to

$3.00, compared with analysts' average estimate of $2.88 per

share, according to data compiled by LSEG.